Clinical Trials Browser

Phase 1 × Lymphoma, Mantle-Cell × pegfilgrastim × Clear all

NCT02728531 2023-11-01

Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma

Phase 1 Completed

Lymphoma, Mantle-Cell

NCT00787969 2018-01-09

Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Phase 1 Completed

Lymphoma, Lymphoma, Mantle-Cell